Ultralow-dose Dexamethasone to Preserve Endogenous Cortisol Stress Response in Nonclassical Congenital Adrenal Hyperplasia: A New Promising Treatment

INTRODUCTION: Nonclassical congenital adrenal hyperplasia (CAH) is characterized by sufficient cortisol and aldosterone production at the cost of androgen overproduction. Hydrocortisone or dexamethasone in supraphysiological doses are current treatment; however, their downside is suppression of endo...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Kaay, Danielle, van den Akker, Erica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166204/
https://www.ncbi.nlm.nih.gov/pubmed/25237318
http://dx.doi.org/10.5812/ijem.14657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166204/
https://www.ncbi.nlm.nih.gov/pubmed/25237318
http://dx.doi.org/10.5812/ijem.14657

Ejemplares similares